Targeted Tissue and Cell-Free Tumor DNA Sequencing of Advanced Lung Squamous-Cell Carcinoma Reveals Clinically Significant Prevalence of Actionable Alterations-Reference-Cited by-同舟云学术

Targeted Tissue and Cell-Free Tumor DNA Sequencing of Advanced Lung Squamous-Cell Carcinoma Reveals Clinically Significant Prevalence of Actionable Alterations

Published:2019-01 Issue:1 Volume:20 Page:30-36.e3
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Lam Vincent K.^ORCID,Tran Hai T.,Banks Kimberly C.,Lanman Richard B.^ORCID,Rinsurongkawong Waree,Peled Nir,Lewis Jeff,Lee J. Jack^ORCID,Roth Jack,Roarty Emily B.,Swisher Stephen,Talasaz AmirAli,Futreal P. Andrew,Papadimitrakopoulou Vassiliki,Heymach John V.,Zhang Jianjun

Funder

MD Anderson Cancer Center

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference38 articles.

1. The international epidemiology of lung cancer: latest trends, disparities, and tumor characteristics;Cheng;J Thorac Oncol,2016

2. The international epidemiology of lung cancer: geographical distribution and secular trends;Youlden;J Thorac Oncol,2008

3. Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non–small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial;Garon;Lancet,2014

4. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non–small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial;Thatcher;Lancet Oncol,2015

5. Mutation incidence and coincidence in non small–cell lung cancer: meta-analyses by ethnicity and histology (mutMap);Dearden;Ann Oncol,2013

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarker Testing for Guiding Precision Medicine for Patients with Non-Small Cell Lung Cancer;CHEST;2024-08

2. Non–Small Cell Lung Cancer, Version 4.2024;Journal of the National Comprehensive Cancer Network;2024-05

3. Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy;Cancers;2024-02-14

4. Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial;Nature Medicine;2024-02-13

5. Afatinib treatment of severe respiratory failure due to malignant lymphangitis in a dialysis patient with squamous cell carcinoma of the lung;BMJ Case Reports;2024-02